Case series, such as Richards et al., also reported decreased AUD symptoms based on alcohol use disorder identification test score in patients receiving Semaglutide for weight loss, further corroborating the potential of GLP-1RAs across formulations [40]
TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial
Researchers are now studying semaglutide and similar drugs for their anti-addiction effects
Most symptoms are mild to moderate and improve significantly within 4-8 weeks of starting treatment or after dose adjustments
Table of Contents What Are Hers Weight Loss Pills
I built this matrix by mapping each row to the single trial endpoint that produced the highest-quality primary evidence as of mid-2026: percent body-weight change for efficacy (Jastreboff 2023, SURMOUNT-1, STEP 1), three-point MACE for cardiovascular (SELECT), MRI-PDFF for hepatic fat (retatrutide Phase 2 sub-analyses, [unverified primary source]), and treatment-emergent adverse event rates for GI burden
